Fulltext

Leveraging the advances in HIV for COVID-19

McMahon JH 1 , Hoy JF 2 , Kamarulzaman A 3 , Bekker LG 4 , Beyrer C 5 , Lewin SR 6

Affiliations 

  • 1 Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia; Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC, Australia
  • 2 Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia
  • 3 Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
  • 5 Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  • 6 Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, 3000 VIC, Australia. Electronic address: sharon.lewin@unimelb.edu.au
Lancet, 2020 10 03;396(10256):943-944.
PMID: 33010825 DOI: 10.1016/S0140-6736(20)32012-2

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications